NASDAQ
Stock News Tech-led selloff caps tough week: US stocks fell as investors rotated out of mega-cap tech after Broadcom (AVGO) and Oracle (ORCL) stoked AI-spending...
WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENC...
The U.S. Food and Drug Administration has approved Innoviva's oral antibiotic for common sexually transmitted infection, offering patients a pill instead of the injection that is currently the only re...
WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced the publication of positive results from a pivotal Phase 3 trial ...
Boston Partners lifted its position in shares of Innoviva, Inc. (NASDAQ: INVA) by 40.6% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 875,084 shares of...
BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious ...
Innoviva, Inc. (NASDAQ: INVA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the seven research firms that are presently covering the stock, MarketBeat reports. One inv...
Connor Clark and Lunn Investment Management Ltd. bought a new position in shares of Innoviva, Inc. (NASDAQ: INVA) during the second quarter, according to the company in its most recent filing with the...
Innoviva (INVA) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.02 per share a year ago....
BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious ...
No price data available for this timeframe.